The Science of Sexual Response: A Comprehensive Guide

Masters & Johnson’s Four-Phase Model (1966) – Updated with Contemporary Neuroscience

1. Desire / Interest Phase (Added by Kaplan, 1979)

  • Motivational state triggered by cues (internal: hormones, thoughts; external: partner, context).
  • Dopamine (mesolimbic), testosterone, estrogen drive seeking behavior.
  • Responsive desire (arousal → desire) common, especially women; not dysfunction.

2. Arousal (Excitement) Phase

  • Vasocongestion: Genital erection (clitoral/penile), vaginal lubrication (transudate), nipple erection, sex flush.
  • Autonomic: Sympathetic ↑ HR, BP, RR; myotonia (muscle tension).
  • Neurochemistry: NO/cGMP mediates vascular smooth muscle relaxation; dopamine, oxytocin, norepinephrine amplify.

3. Plateau Phase

  • Sustained high arousal; orgasmic platform forms (outer third vaginal engorgement).
  • Heart rate 100–175 bpm; BP ↑; respiration ↑; muscle tension peaks.
  • Pre-ejaculate (Cowper’s glands) may contain sperm.

4. Orgasm Phase

  • Pelvic floor contractions: 0.8-sec intervals × 3–15 (uterus, anal sphincter, bulbocavernosus, ischiocavernosus).
  • Ejaculation (male): Emission (sympathetic) → expulsion (somatic).
  • Female ejaculation / squirting: Distinct phenomena (Skene’s glands vs. bladder).
  • Neuroendocrine surge: Oxytocin (bonding), prolactin (satiety/refractory), endorphins (analgesia/euphoria), serotonin (mood).

5. Resolution Phase

  • Vasocongestion subsides (5–30 min); myotonia releases.
  • Refractory period (male): Prolactin-mediated; variable (minutes–hours); shorter with age, novelty, low prolactin.
  • Female capacity: Multiple orgasms possible; no obligatory refractory period.
  • Post-coital dysphoria (PCD): Transient sadness/tearfulness ~5–10% (hormonal drop, psychological).

Individual Variability

  • Non-linear, overlapping phases; desire may emerge at any point.
  • Context (relationship quality, stress, fatigue, trauma, medications, hormones) modulates each phase.
  • Asexuality: low/absent sexual attraction; not a disorder.

Clinical Relevance

Sexual dysfunction defined by phase-specific distress (DSM-5). Assessment includes medical, psychological, relational, cultural factors. Treatment: psychoeducation, sensate focus, pharmacotherapy (PDE5i, flibanserin, bremelanotide), pelvic PT, couples therapy.

Infertility - Related Articles